Company Filing History:
Years Active: 2013-2014
Title: Joan Mazzarelli Sopczynski: Innovator in Therapeutic Inhibitors
Introduction
Joan Mazzarelli Sopczynski is a prominent inventor based in Oreland, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic inhibitors. With a total of 2 patents, her work focuses on innovative solutions for health-related challenges.
Latest Patents
One of her latest patents is centered around polynucleotides encoding therapeutic inhibitors of PAI-1. This invention relates to mammalian PAI-1 ligands and modulators. It includes polypeptides, polypeptide compositions, and polynucleotides that encode polypeptides acting as ligands and/or modulators of PAI-1. The invention also explores polyligands that can modulate PAI-1 activity, as well as localization tethers and promoter sequences for spatial control of these ligands. Furthermore, it discusses inducible gene switches for temporal control and methods for treating or preventing atherosclerosis and fibrosis.
Career Highlights
Joan is currently associated with Intrexon Corporation, where she continues to advance her research and innovations. Her work has been instrumental in developing new therapeutic approaches that could significantly impact patient care.
Collaborations
Joan has collaborated with notable colleagues, including Thomas David Reed and Richard E. Peterson. These partnerships have enhanced her research and contributed to the success of her inventions.
Conclusion
Joan Mazzarelli Sopczynski is a trailblazer in the field of biotechnology, with her innovative patents paving the way for new therapeutic strategies. Her contributions are vital in addressing critical health issues, showcasing the importance of innovation in medicine.